CEO, Managing Director and co-founder, Advinus Therapeutics
Rashmi H. Barbhaiya, Ph.D. is a Pharmaceutical Executive with 27 years of experience in Pharmaceutical R&D. He has a unique blend of management experience in Drug Discovery and Development, Novel Drug Delivery, Herbal and Generic products. He is the CEO, Managing Director and co-founder of Advinus Therapeutics, an innovation-driven pharma company located in Bangalore and Poona, India.
Dr. Barbhaiya started his industrial pharmaceutical career in 1980 with Bristol-Myers Company in the United States where he spent next 21 years. The diversity of his background and experience has played a key role in speedy and successful development of a number of drugs for the treatment of a variety of diseases such as, AIDS and other infectious diseases, cancer, depression, anxiety, hypertension, CHF, diabetes and mild to moderate pain, including migraine. In the capacity of Vice President in the Pharmaceutical Research Institute of Bristol-Myers Squibb, he also played a key role, working with the drug discovery organization, in introducing "developability" as a key criterion in lead optimization, selection of drug candidates for development and to reduce timelines for discovery to development transition as well as for IND filings.
In the year 2002, he returned to India to join Ranbaxy as the President of R & D and led a team of over 900 professionals involved in generic, drug delivery, herbal and innovation-driven new drug research and development activities. He is credited for attracting world-class experienced scientists from overseas and for enhancing an innovation-driven culture to create one of the leading pharmaceutical R & D organizations in India. He was instrumental in creating an R & D alliance between Ranbaxy and GSK, the first of its kind for an Indian company. He is also credited for creating an alliance between Medicine for Malaria Venture (MMV) and Ranbaxy for developing a novel antimalarial which under currently undergoing Phase I clinical trials.
He obtained the Ph.D. degree in Clinical Pharmacology from the St. Bartholomew's Hospital Medical College, University of London. He continued his education through post-doctoral training at the University of Florida and University of Wisconsin. His scientific contributions have resulted in over 150 publications. He has helped to organize a number of scientific symposiums around the world. He is a member of several professional societies, among them are AAPS, ASCPT and ISSX. He has served on the Editorial Boards of Antimicrobial Agents and Chemotherapy and Biopharmaceutics and Drug Disposition journals. Dr. Barbhaiya has received a number of awards for his scientific contributions. Some of these include AAPS Fellow, AAPS Meritorious Manuscript Award, AAiPS Outstanding Achievement Award and Ranbaxy Award for Excellence in Pharmaceutical Research.
